In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous Exophiala species

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 12, 2013, Pages 6395-6398

  Najafzadeh, M J ^a,b   Keisari, M Saradeghi ^b   Vicente, V A ^b,c   Feng, P ^d   Shamsian, S A A ^a   Rezaei Matehkolaei, A ^e   De Hoog, G S ^b,c,d,f,g,h   Curfs Breuker, I ⁱ   Meisj, J F ^i,j  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d SUN YAT SEN UNIVERSITY   (China)

^e AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^h KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

ⁱ CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; ISAVUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ARTICLE; CUTANEOUS EXOPHIALA; EXOPHIALA; FUNGAL STRAIN; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; WATERBORNE EXOPHIALA;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ECHINOCANDINS; EXOPHIALA; FLUCONAZOLE; ITRACONAZOLE; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; NITRILES; PYRIDINES; PYRIMIDINES; TRIAZOLES;

EID: 84887462121     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01629-13     Document Type: Article

References (23)

1. Sudhadham M, Prakitsin S, Sivichai S, Chaiyarat R, Dorrestein GM, Menken SB, de Hoog GS. 2008. The neurotropic black yeast Exophiala dermatitidis has a possible origin in the tropical rain forest. Stud. Mycol. 61:145-155.
2. Li DM, de Hoog GS, Saunte DM, Gerrits van den Ende AH, Chen XR. 2008. Coniosporium epidermidis sp. nov., a new species from human skin. Stud. Mycol. 61:131-136.
3. Li DM, Li RY, de Hoog GS, Wang YX, Wang DL. 2009. Exophiala asiatica, a new species from a fatal case in China. Med. Mycol. 47:101-109.
4. de Hoog GS, Vicente VA, Najafzadeh MJ, Harrak MJ, Badali H, Seyedmousavi S. 2011. Waterborne Exophiala species causing disease in coldblooded animals. Persoonia 27:46-72.
5. Zeng JS, Sutton DA, Fothergill AW, Rinaldi MG, Harrak MJ, de Hoog GS. 2007. Spectrum of clinically relevant Exophiala species in the United States. J. Clin. Microbiol. 45:3713-3720.
6. Heinrichs G, de Hoog GS, Haase G. 2012. Barcode identifiers as a practical tool for reliable species assignment of medically important black yeast species. J. Clin. Microbiol. 50:3023-3030.
7. Manharth A, Lemberge K, Mylniczenko N, Pinkerton M, Pessier AP. 2005. Disseminated phaeohyphomycosis due to Exophiala species in a Galapagos tortoise, Geochelone nigra. J. Herpetol. Med. Surg. 15:20-26.
8. Nyaoke A, Weber ES, Innis C, Stremme D, Dowd C, Hinckley L, Gorton T, Wickes B, Sutton DA, de Hoog GS, Frasca S, Jr. 2009. Disseminated phaeohyphomycosis in weedy seadragons (Phyllopteryx taeniolatus) and leafy seadragons (Phycodurus eques) caused by species of Exophiala, including a novel species. J. Vet. Diagn. Invest. 21:69-79.
9. Vicente VA, Orelis-Ribeiro R, Najafzadeh MJ, Sun J, Guerra RS, Miesch S, Ostrensky A, Meis JF, Klaassen CH, de Hoog GS, Boeger WA. 2012. Black yeast-like fungi associated with lethargic crab disease (LCD) in the mangrove-land crab, Ucides cordatus (Ocypodidae). Vet. Microbiol. 158: 109-122.
10. Najafzadeh MJ, Suh MK, Lee MH, Ha GY, Kim JR, Kim TH, Lee HJ, Choi JS, Meis JF, de Hoog GS. 2013. Subcutaneous phaeohyphomycosis caused by Exophiala equina, with susceptibility to eight antifungal drugs. J. Med. Microbiol. 62:797-800.
11. Badali H, Yazdanparast SA, Bonifaz A, Mousavi B, de Hoog GS, Klaassen CH, Meis JF. 2013. Veronaea botryosa: molecular identification with amplified fragment length polymorphism (AFLP) and in vitro antifungal susceptibility. Mycopathologia 175:505-513.
12. Bonifaz A, Mohammad Davoudi M, de Hoog GS, Padilla-Desgarennes C, Vazquez-Gonzalez D, Navarrete G, Meis JF, Badali H. 2013. Severe disseminated phaeohyphomycosis in an immunocompetent patient caused by Veronaea botryosa. Mycopathologia 175:497-503.
13. Lian X, de Hoog GS. 2010. Indoor wet cells harbour melanized agents of cutaneous infection. Med. Mycol. 48:622-628.
14. Porteous NB, Grooters AM, Redding SW, Thompson EH, Rinaldi MG, de Hoog GS, Sutton DA. 2003. Identification of Exophiala mesophila isolated from treated dental unit waterlines. J. Clin. Microbiol. 41:3885-3889.
15. Taylor JW, Jacobson DJ, Kroken S, Kasuga T, Geiser DM, Hibbett DS, Fisher MC. 2000. Phylogenetic species recognition and species concepts in fungi. Fungal Genet. Biol. 31:21-32.
16. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, second edition: approved standard. CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
17. Deng S, de Hoog GS, Badali H, Yang L, Najafzadeh MJ, Pan B, Curfs-Breuker I, Meis JF, Liao W. 2013. In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis. Antimicrob. Agents Chemother. 57:1974-1977.
18. Feng P, Najafzadeh MJ, Sun J, Ahmed S, Xi L, de Hoog GS, Lai W, Lu C, Klaassen CH, Meis JF. 2012. In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates. Antimicrob. Agents Chemother. 56:6044-6047.
19. Lackner M, de Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, Meis JF. 2012. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob. Agents Chemother. 56:2635-2642.
20. Najafzadeh MJ, Badali H, Illnait-Zaragozi MT, de Hoog GS, Meis JF. 2010. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrob. Agents Chemother. 54:1636-1638.
21. Badali H, de Hoog GS, Sudhadham M, Meis JF. 2011. Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist. Med. Mycol. 49:819-824.
22. Badali H, de Hoog GS, Curfs-Breuker I, Meis JF. 2010. In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection. J. Antimicrob. Chemother. 65:175-177.
23. Revankar SG, Sutton DA. 2010. Melanized fungi in human disease. Clin. Microbiol. Rev. 23:884-928.